Sanofi India to sell its commercial property in Mumbai for Rs 111 crore

22 Jul 2015 Evaluate

Sanofi India has received an approval for selling its commercial property, being land admeasuring 5493.1 square meters bearing Survey No. 54-A Hissa No. 2 and C.T.S. No. 18 of Village Chakala, along with building known as ‘Aventis House' standing thereon, situated at Sir Mathuradas Vasanji Road, Andheri (East) Mumbai for a consideration of Rs 111.00 crore.

The built-up area of the building (comprising of basement and two upper floors) is approximately 69,600 square feet. The transaction is subject to certain conditions precedent and is expected to be completed in the quarter ending September 30, 2015.

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.


Sanofi India Share Price

6052.95 -28.20 (-0.46%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.